C.s en Mepolizumab 100 Mg F.a y Secikinumab 150 Mg
GARANTIZAR EL ABASTECIMIENTO OPORTUNO DEL HOSPITAL REGIONAL DE COPIAPO
2 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 4940-900-SE20 | 07-05-2020 | Novartis Chile S.A. | $2.065.481 |
| 4940-746-SE20 | 23-04-2020 | Glaxosmithkline Chile Farmaceutica Limitada | $3.451.000 |
| 4940-593-SE20 | 22-03-2020 | Novartis Chile S.A. | $2.065.481 |
| 4940-162-SE20 | 26-01-2020 | Novartis Chile S.A. | $1.376.987 |
| 4940-2536-SE19 | 27-12-2019 | Novartis Chile S.A. | $1.721.234 |
| 4940-1993-SE19 | 10-10-2019 | Novartis Chile S.A. | $1.032.740 |
| 4940-1918-SE19 | 17-09-2019 | Novartis Chile S.A. | $1.032.740 |
| 4940-1787-SE19 | 27-08-2019 | Novartis Chile S.A. | $688.494 |
| 4940-1730-SE19 | 20-08-2019 | Novartis Chile S.A. | $688.494 |
| 4940-1725-SE19 | 20-08-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1567-SE19 | 24-07-2019 | Novartis Chile S.A. | $688.494 |
| 4940-1541-SE19 | 18-07-2019 | Novartis Chile S.A. | $688.494 |
| 4940-1549-SE19 | 18-07-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1323-SE19 | 21-06-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1256-SE19 | 17-06-2019 | Novartis Chile S.A. | $688.494 |
| 4940-1086-SE19 | 22-05-2019 | Novartis Chile S.A. | $688.494 |
| 4940-937-SE19 | 14-05-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $1.380.400 |
| 4940-895-SE19 | 08-05-2019 | Novartis Chile S.A. | $688.494 |
| 4940-841-SE19 | 20-04-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $1.380.400 |
| 4940-685-SE19 | 04-04-2019 | Novartis Chile S.A. | $688.494 |
| 4940-616-SE19 | 24-03-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-345-SE19 | 20-02-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $1.380.400 |
| 4940-132-SE19 | 24-01-2019 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1215-SE18 | 15-01-2019 | Novartis Chile S.A. | $1.376.987 |
| 4940-2345-SE18 | 18-12-2018 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-2159-SE18 | 17-11-2018 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-2026-SE18 | 22-10-2018 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1858-SE18 | 04-10-2018 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1796-SE18 | 22-09-2018 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1544-SE18 | 20-08-2018 | Glaxosmithkline Chile Farmaceutica Limitada | $690.200 |
| 4940-1216-SE18 | 10-07-2018 | Glaxosmithkline Chile Farmaceutica Limitada | $1.380.400 |
Fuente original:ficha mercadopublico.cl
